InsidersTradesSigma
Total declarations
Company
▲ Purchases (9 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Appelbaum Kevin J, Chief Executive Officer. Officer active across 1 companies, notably Better Therapeutics, Inc.. Aggregated, 9 disclosures have been published. Total volume traded: €36k. The latest transaction was filed on 31 March 2022 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations9 total
€4,4452,500 shares@ €1.777981.54% mcap12.5% of flow
Common Stock
SEC:0000899243-22-013342:0·
Ideal exit: 26 Dec 2022 (T+270)
€4,0911,000 shares@ €4.091275.05% mcap26.3% of flow
Common Stock
SEC:0000899243-21-049425·
Ideal exit: 16 Sept 2022 (T+270)
€4,0911,000 shares@ €4.091275.05% mcap11.5% of flow
Common Stock
SEC:0000899243-21-049425:0·
Ideal exit: 16 Sept 2022 (T+270)
€3,135750 shares@ €4.179457.50% mcap20.2% of flow
Common Stock
SEC:0000899243-21-048904·
Ideal exit: 11 Sept 2022 (T+270)
€3,135750 shares@ €4.179457.50% mcap8.8% of flow
Common Stock
SEC:0000899243-21-048904:0·
Ideal exit: 11 Sept 2022 (T+270)
€5,2911,000 shares@ €5.290997.06% mcap34.1% of flow
Common Stock
SEC:0000899243-21-048151·
Ideal exit: 6 Sept 2022 (T+270)
€5,2911,000 shares@ €5.290997.06% mcap14.9% of flow
Common Stock
SEC:0000899243-21-048151:0·
Ideal exit: 6 Sept 2022 (T+270)
€3,021500 shares@ €6.042755.43% mcap19.4% of flow
Common Stock
SEC:0000899243-21-046974·
Ideal exit: 29 Aug 2022 (T+270)
€3,021500 shares@ €6.042755.43% mcap8.5% of flow
Common Stock
SEC:0000899243-21-046974:0·
Ideal exit: 29 Aug 2022 (T+270)
9 of 9 declarations
About Appelbaum Kevin J
Kevin J. Appelbaum is the Chief Executive Officer of Better Therapeutics, Inc. He leads the company in developing innovative therapeutic solutions. His role is crucial for the growth strategy and the company's impact on the healthcare market.
